Louis joined Financière Arbevel in 2016 as an equity analyst for the Pluvalca Health fund. He launched the Private Equity Healthcare division at Financière Arbevel in 2018 and has been co-managing it since.

Louis is a board member for portfolio companies amongst which Germitec, NG Biotech, and TransCure BioServices.